Workflow
亿帆医药(002019) - 2015年12月29日投资者关系活动记录表

Group 1: Price Trends and Market Conditions - The recent global market has seen an upward trend in the prices of vitamin products, including calcium pantothenate (vitamin B5), which was at a low price point in 2015 and is expected to rise [2] - The tightening of domestic environmental regulations may have led to some manufacturers being unable to fully release production capacity, resulting in a market characterized by tight supply and increased production costs [2] - The company anticipates that the price of calcium pantothenate will continue to rise in the future, although the duration and extent of the increase are uncertain and ultimately determined by market conditions [2] Group 2: Production and Capacity - The total production capacity for the company's pantothenic acid series products is 12,000 tons per year [2] - The company will decide on order placements based on market conditions and actual production situations, with prices generally following market trends [2] Group 3: Strategic Development - The company's future strategic focus includes three main areas: pharmaceutical raw materials, drug formulations, and the healthcare sector [2] - The company aims to enhance innovation and promote business integration and upgrading while achieving some success in internationalization through strategies like "going out" and "bringing in" [3] - In developing regions, the company plans to establish local factories to supply domestic products, while in developed regions like Europe and the U.S., it will pursue acquisitions of international pharmaceutical companies to expand its global market presence [3]